Android app on Google Play

Lazard Capital Upgrades Alexion Pharmaceuticals (ALXN) to Buy

February 20, 2013 7:34 AM EST Send to a Friend
Get Alerts ALXN Hot Sheet
Price: $169.17 -1.8%

Rating Summary:
    11 Buy, 7 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 13 | New: 28
Trade ALXN Now!
Join SI Premium – FREE
Lazard Capital upgraded Alexion Pharmaceuticals (NASDAQ: ALXN) from Neutral to Buy.

For an analyst ratings summary and ratings history on Alexion Pharmaceuticals click here. For more ratings news on Alexion Pharmaceuticals click here.

Shares of Alexion Pharmaceuticals closed at $83.39 yesterday.




You May Also Be Interested In


Related Categories

Upgrades

Related Entities

Lazard

Add Your Comment